In endometrial cancer cell lines, miR-195 decreased cell viability, migration and invasion, and increased the expression of tissue inhibitor of metalloproteinase 2 (TIMP2), while decreasing MMP2 and MMP9. Here, TIMP2 is linked to endometrial cancer.